3 Reasons to Seek Out More Stable Stocks

With markets experiencing a dip on Friday, more stable stocks could be on the agenda.

Jan 26, 2014 at 9:00PM

Stability is something that's arguably not at the forefront of investors' minds at the moment. With 2013 being such a great year for the stock market, it seems as though many market participants are very much in "risk-on" mode and are keeping both eyes firmly fixed on growth prospects and whether a company can hit that all-important double-digit growth rate.

However, the large fall in the S&P 500 on Friday could be a timely reminder that markets don't always go up, and, as such, it could be the case that investors begin to seek out one or two more stable companies in case the market trades sideways or experiences a further dip.

So what is stability? Of course, different investors will have different viewpoints on what defines a stable company, but it could be reasonably expected that a stable company has a good track record of delivering profits, because this could indicate that it is more likely to continue to have a healthy bottom line -- even if economic conditions worsen in future years.

In addition, a stable company should have a relatively generous yield, so that if capital growth is not forthcoming in the future, investors in the stock can still rely on an income in the form of a dividend with which to pay the bills, or to invest in other stocks at suppressed prices.

Furthermore, a stable business may have a beta of less than 1. This means that it has been less volatile than the wider market over a specific time period (usually six to 12 months) and should, in theory, fall by a smaller amount than the wider market in the future.

Of course, the flip side is that it should (in theory) also gain by less than the market in the future, meaning it should outperform the rest of the index in a downturn but underperform in an upturn.

So here are three businesses in the health-care space that could fit the bill for investors seeking more stable stocks:

1. Pfizer (NYSE:PFE) -- over the past four years it has grown revenue at an annualized rate of 5.1%, with profits growing by 5.7% over the same period, as the company was able to grow the top line ahead of its cost base. In addition, it pays a yield of 3.2%, which is well above the S&P 500 yield of 2.2%. Furthermore, Pfizer's beta is 0.8, which further highlights its credentials as a more stable stock.

2. Merck (NYSE:MRK) -- although revenue growth has been highly impressive in the past four years (growing by 18.7% per annum), profits have been fairly volatile. Although profits have been made in all years, they have ranged from $1.6 billion to $15.3 billion, thereby highlighting that Merck's performance as a business isn't quite as stable as that of Pfizer. However, as a stock, it offers a lower beta than Pfizer (0.6 versus 0.8) and a slightly higher dividend (3.3% versus 3.2%).

3. Johnson & Johnson (NYSE:JNJ) -- although revenue is only slightly higher now than it was four years ago and profits are slightly lower than in 2008, Johnson & Johnson remains among the most stable stocks in the health-care sector, with the historical revenue and profit range being relatively narrow. Its beta of 0.8, combined with a yield of 2.8% (versus the S&P 500 yield of 2.2%), mark it out as a potentially more stable option for risk-conscious investors.

So while 2014 could be another great year for the S&P 500, the events of Friday showed that growth and recovery is not a given. Therefore, keeping an eye on stability could prove to be a worthwhile counter to further market turbulence.

The Motley Fool's best idea for 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Fool contributor Peter Stephens has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers